Life Sciences Strategy Summit on IP & Exclusivity returns to Munich in October, carrying IPKat readers’ discount

Networking at "Katzentempel"

The Katfriends at Kisaco Research wish to inform IPKat readers that the popular Life Sciences Strategy Summit on IP & Exclusivity is returning for yet another edition, which will take place in Munich on 13-15 October 2025.

400+ leading life science legal specialists, with a 50% in-house counsel ratio, will gather to gain a comprehensive, cross-disciplinary understanding of the exclusivity landscape in Europe.

This year’s agenda includes the following topics:
  • SPC and PTE protection across key jurisdictions, with a focus on the strategic insights needed to extend product lifecycle.
  • Patent strategy challenges, alongside essential regulatory developments impacting product development and approval.
  • The evolving litigation environment, including the latest trends in competition law affecting both originator and generic companies.

Also key to the 2025 edition are the following aspects:
  • Three days of expert-led sessions on the UPC, divisional patents, clinical trial regs, and more – all focused on commercially critical legal issues.
  • 15+ hours of networking, 1:1 meetings, roundtables, and receptions – all via the conference’s easy-to-use event app.
  • Meeting top legal decision-makers from major originator, biotech, biosimilar, and generic companies worldwide.

The full agenda is available here.

IPKat readers are entitled to a 15% discount in the registration fee using VIP code IPKATSM15 at checkout. For further information and to register, click here.
Do you want to reuse the IPKat content? Please refer to our Policies section. If you have any queries or requests for permission, please get in touch with the IPKat team.
Print | Share by email

Comments

← Previous Post Next Post →